# Novo Nordisk A/S will integrate OpenAI’s artificial intelligence across the company.

*business · news · 2026-04-14 · Deccan Chronicle*

## Key points

- Novo Nordisk will fully integrate OpenAI's AI across all company operations by year-end.
- The partnership extends beyond ChatGPT access, involving pilot programs in R&D, manufacturing, and commercial units.
- Novo aims to use OpenAI's AI to accelerate drug target identification and clinical trial design.
- CEO Mike Doustdar has eliminated about 9,000 jobs to foster a faster, performance-driven culture.

**Companies:** OpenAI, Novo Nordisk A/S, Nvidia Corp
**Countries:** Denmark, United States

[Read the full story on Deccan Chronicle](https://www.deccanchronicle.com/lifestyle/health-and-well-being/novo-nordisk-taps-openai-to-speed-development-of-new-obesity-drugs-1950353)

---

Canonical: https://newsio.io/n/ce976391-b99d-4f85-bb44-bdbbbdf1eb9e/novo-nordisk-as-will-integrate-openais-artificial-intelligence-across-the-compan
Summarized by Newsio from Deccan Chronicle. https://newsio.io/how-it-works